相关实验视频

Updated: Sep 10, 2025

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

完善晚期古典霍奇金淋巴瘤的风险分层:临床预测模型的批判性分析

Oguzhan Koca^1,2, Ahmet Emre Eskazan³

¹Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

British journal of haematology

|August 22, 2025

概括

经典霍奇金淋巴瘤 (cHL) 的风险预测模型正在发展. 像A-HIPI这样的新型模型提供了更好的准确性, 但整合动态标记是个性化治疗和更好的结果的关键.

科学领域:

血液学
癌症学
医疗信息学

背景情况:

经典霍奇金淋巴瘤 (cHL) 是一种可治愈的恶性瘤,但预后有所不同.
由于治疗的进步,现有的预测模型,如国际预测得分 (IPS) 面临预测性能下降.
在cHL中需要更准确的风险分层工具.

研究的目的:

审查晚期cHL的预后模型的演变.
讨论当前模型的优点和局限性,包括新的A-HIPI指数.
强调整合动态生物标志物和机器学习的必要性,以改善风险评估和个性化治疗.

主要方法:

对cHL临床预测模型的综合文献综述.
对预后评分系统 (IPS,更新的IPS,IPS-3,A-HIPI) 的发展和完善进行分析.
讨论新兴的方法,如临时PET/CT,机器学习和多态学.

主要成果:

对cHL的预测模型已经从IPS演变为更新的A-HIPI,其中包含连续变量.
目前的模型没有整合动态治疗反应标志物,例如临时PET/CT,这些标志物已被证明具有预后价值.
需要进一步验证A-HIPI,特别是在老年患者中.

结论:

精细的预后模型对于提高cHL风险分层至关重要.
未来的模型应该整合动态生物标志物和治疗反应指标,以更精确地评估风险.
机器学习和多态学对个性化CHL治疗和优化患者结果具有前景.

关键词:

一个HIPI 霍奇金淋巴瘤其他国家预测模型预后情况

更多相关视频

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...